Department of Pulmonary and Critical Care Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Front Public Health. 2023 Aug 21;11:1168249. doi: 10.3389/fpubh.2023.1168249. eCollection 2023.
To gain insight into medication satisfaction and factors associated with chronic respiratory disease, particularly chronic obstructive pulmonary disease (COPD) in older adults, focusing on public health issues and improving the health of the older adult population.
This cross-sectional study was conducted from October 2022 to November 2022 in 24 hospitals in different regions of Hunan Province, China. Older adult patient treatment satisfaction was assessed using the Treatment Satisfaction Questionnaire for Medication version II. Multiple regression analysis was used to identify factors independently associated with patient treatment satisfaction.
Only 15.9% of all patients scored above 80 in the effectiveness domain, while 11.6 and 16.5% scored above 80 in the convenience and global satisfaction domains, respectively, while 17.3% reported having side effects. Interstitial lung disease was associated with lower drug satisfaction than other disorders ( < 0.05). Multifactorial regression analysis showed that age, education background, profession, and smoking status were independently associated with satisfaction among patients with chronic respiratory diseases ( < 0.05). Education background, profession, CAT score, number of acute exacerbations, duration of home oxygenation and duration of home ventilator use were independently associated with satisfaction in patients with COPD ( < 0.05).
Low satisfaction with chronic respiratory drug therapy was associated with age, education background, profession and smoking status. Satisfaction was lower for patients with interstitial lung disease. For COPD, CAT score, education background, profession, number of acute exacerbations, home oxygen and ventilator use influence satisfaction. Clinicians can identify appropriate patients and communicate effectively with them throughout treatment and follow-up, vigorously promote smoking cessation and home oxygen therapy, increase medication satisfaction, especially among older adults, and in turn improve public health and the quality of life of older adults.
深入了解老年人慢性呼吸道疾病（尤其是慢性阻塞性肺疾病，COPD）的药物满意度和相关因素，重点关注公共卫生问题，改善老年人群的健康状况。
本横断面研究于 2022 年 10 月至 11 月在中国湖南省 24 家不同地区的医院进行。采用药物治疗满意度问卷第二版评估老年患者的治疗满意度。采用多元回归分析确定与患者治疗满意度独立相关的因素。
只有 15.9%的患者在疗效域得分高于 80，而在便利性和总体满意度域分别有 11.6%和 16.5%的患者得分高于 80，同时有 17.3%的患者报告有副作用。间质性肺疾病与其他疾病相比，药物满意度较低（<0.05）。多因素回归分析显示，年龄、教育背景、职业和吸烟状况与慢性呼吸道疾病患者的满意度独立相关（<0.05）。教育背景、职业、CAT 评分、急性加重次数、家庭氧疗时间和家庭呼吸机使用时间与 COPD 患者的满意度独立相关（<0.05）。
慢性呼吸道疾病药物治疗的满意度低与年龄、教育背景、职业和吸烟状况有关。间质性肺疾病患者的满意度较低。对于 COPD，CAT 评分、教育背景、职业、急性加重次数、家庭氧疗和呼吸机使用影响满意度。临床医生可以在整个治疗和随访过程中识别合适的患者并与他们进行有效沟通，大力推广戒烟和家庭氧疗，提高药物满意度，尤其是在老年人中，从而改善公共卫生和老年人的生活质量。
